Management of candidiasis Management of Candida species infections in critically ill patients
- 1 December 2003
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (12) , 772-785
- https://doi.org/10.1016/s1473-3099(03)00831-4
Abstract
No abstract availableKeywords
This publication has 166 references indexed in Scilit:
- Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary InvestigatorsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic PatientsClinical Infectious Diseases, 2000
- A Pilot Study of the Management of Uncomplicated Candidemia with a Standardized Protocol of Amphotericin BClinical Infectious Diseases, 1999
- A Computer-Assisted Management Program for Antibiotics and Other Antiinfective AgentsNew England Journal of Medicine, 1998
- Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patientsInfection, 1996
- Management of deepCandida infection in surgical and intensive care unit patientsIntensive Care Medicine, 1994
- Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979